CONSENT OF INDEPENDENT ACCOUNTANTS
Published on June 19, 1997
EXHIBIT 24.3
CONSENT OF INDEPENDENT ACCOUNTANTS
We consent to inclusion in this Post-Effective Amendment No. 3 to the
Registration Statement on Form SB-2 of our report dated February 7, 1997 (with
respect to Note K[2], February 21, 1997) on our audits of the financial
statements of Cytoclonal Pharmaceutics Inc, a Delaware corporation as of
December 31, 1996 and for the two years ended December 31, 1996 and for the
period September 11, 1991 (inception) through December 31, 1996. We also
consent to the reference of our firm under the captions "Experts" and "Selected
Financial Data" in the Prospectus.
New York, NY
June 16, 1997